Skip to main content

Advertisement

Log in

Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background

During successful chemotherapy of osteosarcomas tumour size does not diminish significantly because the therapy has limited impact on the mineralized matrix of the tumour. Treatment response is considered successful if, histologically, more than 90% of tumour cells show necrosis.

Objective

To determine if osteosarcomas change their water diffusion during preoperative chemotherapy in relation to the amount of tumour necrosis.

Materials and Methods

Eight patients (age 11–19 years) with histologically proven limb osteosarcoma underwent T1-weighted, fat-suppressed T2-weighted and contrast-enhanced T1-weighted spin-echo imaging together with diffusion-weighted EPI sequences (b = 700) at 1.5 T before and after five cycles of standard chemotherapy. Tumour volume and apparent diffusion coefficient (ADC) maps were calculated before and after chemotherapy. The degree of tumour necrosis after chemotherapy was assessed using the histological Salzer-Kuntschik classification (grades 1–6).

Results

During chemotherapy, the ADC values of osteosarcomas changed significantly. The ADC of untreated tumour was 2.1 ± 0.4 × 10−3 mm2/s (mean ± SD) (95% CI 1.6–2.0). The ADC of chemotherapy-treated sarcomas was 2.5 ± 0.4 × 10−3 mm2/s (95% CI 1.8–2.2). Necrotic areas, which were confirmed by macroscopic examination, showed ADC values up to 2.7 × 10−3 mm2/s. Four patients with little viable tumour tissue within the neoplasm (Salzer-Kuntschik grades 1–2) had an increase in ADC of 0.4 up to 0.7 × 10−3 mm2/s. Four patients with larger areas of viable tumour (Salzer-Kuntschik grade 4) showed a lesser increase in ADC of 0.0 up to 0.3 × 10−3 mm2/s. The differences in ADC values in tumour tissue before and after chemotherapy were highly significant (P = 0.01).

Conclusion

During chemotherapy of osteosarcomas, tumour ADC changes are related to the degree of tumour necrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hoffer FA, Nikanorov A, Reddick WE, et al (2000) Accuracy of MR imaging for detecting epiphyseal extension of osteosarcoma. Pediatr Radiol 30:289–298

    Article  PubMed  CAS  Google Scholar 

  2. Lang P, Johnston JO, Arenal-Romero F, et al (1998) Advances in MR imaging of pediatric musculoskeletal neoplasms. Magn Reson Imaging Clin N Am 6:579–604

    PubMed  CAS  Google Scholar 

  3. Lang P, Wendland M, Saeed M, et al (1998) Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion weighted MR imaging. Radiology 206:227–235

    PubMed  CAS  Google Scholar 

  4. Ross BD, Moffat BA, Lawrence TS, et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2:581–587

    PubMed  CAS  Google Scholar 

  5. Uhl M, Saueressig U, Kontny U, et al (2006) Osteosarcoma: preliminary results of in vivo assessment of tumour necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 41:618–623

    Article  PubMed  CAS  Google Scholar 

  6. Baur A, Reiser MF (2000) Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 29:555–562

    Article  PubMed  CAS  Google Scholar 

  7. Parker GJ (2004) Analysis of MR diffusion weighted images. Br J Radiol 77:S176–S185

    Article  PubMed  Google Scholar 

  8. Salzer-Kuntschik M, Brand G, Delling G (1983) Determination of the degree of morphological regression following chemotherapy in malignant bone tumors. Pathologe 4:135–141

    PubMed  CAS  Google Scholar 

  9. Sanchez RB, Quinn SF, Walling A, et al (1990) Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens. Radiology 174:237–240

    PubMed  CAS  Google Scholar 

  10. Thoeny HC, De Keyzer F, Vandecaveye V, et al (2005) Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492–499

    Article  PubMed  Google Scholar 

  11. Thoeny HC, De Keyzer F, Chen F, et al (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234:756–764

    Article  PubMed  Google Scholar 

  12. Theilmann RJ, Borders R, Trouard TP, et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831–837

    Article  PubMed  Google Scholar 

  13. Deng J, Miller FH, Rhee TK, et al (2006) Diffusion weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17:1195–1200

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Markus Uhl.

Additional information

Supported by Grant DFG# u103

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uhl, M., Saueressig, U., Koehler, G. et al. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36, 1306–1311 (2006). https://doi.org/10.1007/s00247-006-0324-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-006-0324-x

Keywords

Navigation